A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis Read more about A Study to Evaluate the Safety of Lebrikizumab Compared to Topical Corticosteroids in Adult Patients With Atopic Dermatitis
An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency Read more about An Expanded Access Protocol for Sebelipase Alfa for Patients With Lysosomal Acid Lipase Deficiency
Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section Read more about Evaluation of the Safety and Efficacy of EXPAREL When Administered Into the TAP in Subjects Undergoing Cesarean Section
A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine Read more about A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors Read more about Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer Read more about Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer Read more about Study of Erlotinib With or Without Investigational Drug (U3-1287) in Subjects With Advanced Non-small Cell Lung Cancer
A Study of RO5028442 in Adult Male High-Functioning Autistic Patients Read more about A Study of RO5028442 in Adult Male High-Functioning Autistic Patients
Clarification of Optimal Anticoagulation Through Genetics Read more about Clarification of Optimal Anticoagulation Through Genetics
A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248 Read more about A SU011248 Expanded Access Protocol for Systemic Therapy of Patients With Metastatic Renal Cell Carcinoma Who Are Ineligible for Participation in Other SU011248 Protocols But May Derive Benefit From Treatment With SU011248